Buscato, Reynamae -.

HRN: 26-84-40  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/20/2025
CEFUROXIME 750MG (VIAL)
03/20/2025
03/27/2025
IV
750mg
Q8H
Acute Bacterial Infection
Waiting Final Action 
03/20/2025
CEFUROXIME 750MG (VIAL)
03/20/2025
03/27/2025
IV
750mg
Q8H
UTI
Waiting Final Action 
03/22/2025
CEFTRIAXONE 1G (VIAL)
03/22/2025
03/28/2025
IVT
2g
Q24
Cholecystitis
Waiting Final Action 
03/27/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/27/2025
04/02/2025
IVT
2.25gm
Q8
7days
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: